Drug-coated Balloon in de Novo Chronic Total Occlusions
NCT ID: NCT05977842
Last Updated: 2026-01-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
309 participants
OBSERVATIONAL
2012-12-15
2025-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
DCB Treatment in CTO Guided by IVUS
NCT06050096
Resting Full-cycle Ratio-guided Step by Step Balloon Dilation
NCT05107024
Shockwave IVL + DCB
NCT05625997
A Prospective, Multi-Center, Pivotal Study to Evaluate the Safety and Effectiveness of the NovaCross™ Micro-catheter in Facilitating Crossing Chronic Total Occlusion (CTO) Coronary Lesions
NCT02477579
Chronic Total Occlusion Registry
NCT02352818
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CTO PCI using DCB-only strategy
Successful CTO recanalization treated with DCB at the occlusion site
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* in-stent CTO
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Cardiology, Warsaw, Poland
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maksymilian Opolski, MD
Role: PRINCIPAL_INVESTIGATOR
National Institute of Cardiology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Graz University Heart Center
Graz, , Austria
Klinik Ottakring
Vienna, , Austria
Jolimont Hospital
Uccle, , Belgium
Županijska bolnica Čakovec
Čakovec, , Croatia
University Hospital Brno
Brno, , Czechia
Liberec Regional Hospital
Liberec, , Czechia
Kardiologické Centrum AGEL
Pardubice, , Czechia
Lille University Hospital
Lille, , France
Hospital zum Heiligen Geist
Kempen, , Germany
University of Debrecen
Debrecen, , Hungary
University of Szeged
Szeged, , Hungary
Shamir Assaf Harofeh MC
Be’er Ya‘aqov, , Israel
Humanitas University
Milan, , Italy
Villa Sofia Hospital
Palermo, , Italy
Santissima Annunziata Hospital
Savigliano, , Italy
Medical University of Bialystok
Bialystok, , Poland
American Heart of Poland
Bielsko-Biala, , Poland
John Paul II Western Hospital
Grodzisk Mazowiecki, , Poland
Jagiellonian University Medical College
Krakow, , Poland
John Paul II Hospital
Krakow, , Poland
MSWiA Hospital
Lodz, , Poland
1st Military Hospital
Lublin, , Poland
MSWiA Hospital
Lublin, , Poland
Poznan University of Medical Sciences
Poznan, , Poland
SP ZOZ Hospital
Puławy, , Poland
MSWiA Hospital
Rzeszów, , Poland
Bielanski Hospital
Warsaw, , Poland
Military Institute of Medicine
Warsaw, , Poland
National Institute of Cardiology
Warsaw, , Poland
Dr Alfred Sokolowski Specialist Hospital
Wałbrzych, , Poland
Wroclaw Medical University
Wroclaw, , Poland
Silesian Center for Heart Disease
Zabrze, , Poland
Heart Institute
Cluj-Napoca, , Romania
Emergency Clinical County Hospital
Oradea, , Romania
Hospital Clínico Universitario de Valladolid
Valladolid, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CTO-DENOVO
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.